CFDs and spread bets are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Financial market research and analysis

Our analysts have their fingers on the pulse of the world's financial market news.

CFD trading is high risk and may not be suitable for everyone.
Risk-off after Trump, pharma murdered

Risk-off after Trump presser rant

Far from being the catalyst for the next leg higher in the ‘Trump rally’, The Donald’s press conference seems to have called a temporary top. The publishing of the unsubstantiated intelligence dossier understandably rattled the President-elect and probably shifted the emphasis of the presser. Markets were waiting for “pro-growth” Trump and they got “fake news” Trump. Stocks markets were mostly lower while traditional havens like gold and the Japanese yen rose in response.

 All is not lost though. Not talking about fiscal stimulus on this occasion, doesn’t mean it’s cancelled. We view the sell-off as direct response to the specific comments targeting defence and pharmaceutical companies, rather than a general loss of confidence in the pro-growth agenda. If one can look through Trump’s bluster, high levels of fiscal spending, given America’s high debt levels, would be much more sustainable if the government can broker better deals in areas such as healthcare and defence.

 

Pharma stocks get murdered

The sentence “They’re getting away with murder” was all it took to see healthcare stocks in the US then Europe plummet. Donald Trump’s views on the pharmaceutical industry were thought to be more tempered than Hillary Clinton’s. The focus on the industry during the presser came out of left-field.

 A couple of high profile price gauging cases meant the momentum had already been building for a crackdown on high drug prices. If the rhetoric follows through to action, Donald Trump has just made the pharmaceutical industry un-investable. At least from a US standpoint, biotech led the last bull market so a rule of thumb is that it was never going to lead the ‘Trump rally’, should it continue.

 European-listed drug makers weren’t saved the pain. The likes of Shire, Hikma and AstraZeneca in the UK as well as Bayer in Germany all dropped in sympathy with industry peers in the US. The healthcare companies in Europe are typically global in nature and quite interconnected with the US so Trump’s comments bodes ill for the sector.

 

A retail earnings onslaught

An onslaught of Christmas updates from top UK retailers, almost all of which surprised to the upside shielded UK stocks from a generally risk-off tone following Donald Trump’s first press conference. M&S, John Lewis, Tesco, Debenhams, JD Sports, Supergroup, ABF and AO World were amongst those reporting.

14-12-2020

GBP jumps on Brexit talks extension
The British pound has jumped in early trading this week after the UK Prime Minister and EU Commission President agreed to extend Brexit talks beyond Sunday. MARKETSThe S&P 500 fell on Friday, wrapping up a losing week, as the outlook for additional fiscal… Read more

10-12-2020

AirBnB IPO today
At its IPO price of $6 per share, Airbnb ABNB, is expected to raise at least $3.5 billion with an initial market capitalization topping $40 billion. MARKETSStocks fell on Wednesday, retreating from the record highs set earlier in the day, as tech shares strug… Read more

9-12-2020

S&P 500 closes over 3,700
MARKETSThe S&P 500 closed above 3,700 for the first time ever on Tuesday as Pfizer started to roll out its coronavirus vaccine in the U.K., lifting hope of the economy recovering in the near future. The Dow Jones gained 0.4% while the Nasdaq Composite clim… Read more

8-12-2020

Global stock market cap reaches $100 trillion for 1st time
The value of all the stocks in the world put together has reached a giant $100 trillion for the first time. MARKETSThe Dow fell 0.69% Monday, led by Intel and broad-based weakness in value stocks as rising Covid-19 restrictions offset optimism over an imminen… Read more

4-12-2020

Pfizer vaccine supply chain problems
MARKETS The S&P 500 fell slightly from record high. Major U.S stocks indices cut gains quickly in the final hour of trading after Dow Jones reported Pfizer now expects to ship half of the doses it had previously planned this year after finding raw materia… Read more

2-12-2020

Dollar Purge Continues
The US dollar dropped to fresh two-and-a-half year lows on Tuesday, with EUR/USD rising above the widely-watched 1.20 handle. MARKETSNews• Stocks in Asia-Pacific were mixed in Wednesday morning trade after major indexes on Wall Street surged to record highs o… Read more

1-12-2020

Bitcoin hits record high
The price of Bitcoin climbed 8.7% on Monday to reach a fresh record high of $19,857.03 - overtaking its previous peak made in 2017. MARKETSNews• Asia stocks rise as the Caixin/Markit manufacturing Purchasing Managers’ Index for November came in at 54.9 — its… Read more

30-11-2020

OPEC meeting starts
Today OPEC+ begin a 2-day meeting to decide whether to begin producing an extra 2 million barrels per day of oil, or delay for another 3-6 months. MARKETSNews• Asia-Pacific markets are mixed this morning while S&P 500 futures are down half a per cent. Ind… Read more